Please login to the form below

Not currently logged in
Email:
Password:

Kantar Health appoints two senior researchers

Dr Theano Anasta and Svetlana Gogolina join research firm

Dr Theano Anasta and Svetlana Gogolina have joined market research firm Kantar Health as senior researchers in its UK team.

Dr Anasta (pictured right) joins from research company Holden Pearmain, where she was head of advanced methods and deputy managing director.

Other positions held prior to her time at Holden Pearmain include director of the marketing science centre at Research International UK.

Kantar-Svetlana-GogolinaKantar Theano Anasta

Gogolina's (pictured left) appointment is a return to Kantar after leaving the company in 2011 to become research director at Holden Pearmain.

She is now advanced methods consultant after serving as senior methodologist in her first spell.

Gogolina also spent seven months last year as partner in CLOUT.

“Theano and Svetlana bring extensive experience in designing complex studies and consulting with senior clients,” said Jim Needell, managing director of Kantar Health in the UK.

“They will help us deliver on our objectives of meeting our clients' growing needs and addressing their central business questions around managing product launch programmes and how to promote and measure their performance.”

29th January 2013

From: Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics